Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-10-02

XBiotech Inc. (XBIT)

CEO Sushma Shivaswamy was paid $570,992 in fiscal year 2025, ↓ down 13.2% from fiscal year 2024 (SEC filing 0001171843-26-006362 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$30,134,204
John Simard total, FY2025
Former President & Chief Executive Officer — highest-paid officer; CEO Sushma Shivaswamy: $570,992
—
CEO (Sushma Shivaswamy) pay percentile vs peers
—
CEO-to-median pay ratio
—
Say-on-pay support, latest vote

Ask our research desk, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Sushma Shivaswamy (Interim Chief Executive Officer & Chief Scientific Officer), FY2025 total compensation $570,992 (base salary $468,557) [exec_comp, SEC accession 0001171843-26-006362, filed 2026-10-02]
01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
John Simard$1,250,000$8,530,442—$3,000,000——$17,353,762$30,134,204
Former President & Chief Executive Officer
Sushma Shivaswamy468,55790,000000012,436570,992
Interim Chief Executive Officer & Chief Scientific Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
John Simard$30,134,204$6,245,581—↑ +23,888,623
Sushma Shivaswamy570,992657,572—↓ −86,580

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read XBiotech Inc.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper XBIT reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against XBIT
1 company names XBIT as a compensation peer

Each company listed discloses XBIT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named XBIT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
John SimardOption48,1259.45—
John SimardOption500,00011.12—
Sushma ShivaswamyOption50,0004.24—
Sushma ShivaswamyOption100,00012.67—
HuOption10,00012.64—
Sushma ShivaswamyOption100,0003.84—
HuOption10,00010.36—
HuOption5,0005.26—
John SimardOption61,5164.24—
Sushma ShivaswamyOption15,0005.26—
John SimardOption110,7404.44—
Sushma ShivaswamyOption150,0004.13—
John SimardOption150,0007.45—
John SimardOption1,026,2283.52—
Sushma ShivaswamyOption100,00010.36—
HuOption30,0003.84—
05

Incentive-plan design — the Compensation Discussion & Analysis

The Company's executive compensation program is designed to attract and retain key executives critical to the Company's success and to align the financial interests of executive officers with those of shareholders. The program seeks to motivate and reward executives by ensuring that a significant portion of compensation opportunities is directly related to the achievement of financial and operational goals that impact shareholder value.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultant—
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
09

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)—
Stock ownership guideline—
10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1XBiotech Inc.2025Sushma Shivaswamy$468,557$0$0$0$570,992

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10d

Frequently asked questions

Who was the highest-paid executive at XBiotech Inc. in fiscal 2025?
As disclosed, John Simard (Former President & Chief Executive Officer) was the highest-paid executive at XBiotech Inc. in fiscal 2025, with total compensation of $30,134,204.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, John SimardDEF 14A2026-10-020001171843-26-006362Section “Executive Compensation”. As printed: 30,134,204. Filing ↗
2Section 01, Sushma ShivaswamyDEF 14A2026-10-020001171843-26-006362Section “Executive Compensation”. As printed: 570,992. Filing ↗machine: r3 · c24 · span 252665–252672
3Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
4XBiotech Inc. (subject), Section 10b CEO totalDEF 14A2026-10-020001171843-26-006362CEO total compensation as printed in XBiotech Inc.'s own proxy. As printed: 570,992. Filing ↗machine: r3 · c24 · span 252665–252672

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat

A confirmation now and one email when Pro opens, and nothing else. Privacy